- Country: Macedonia
- Summary: Medicines-3
- MKT Ref No: 123584301
- Deadline: 01 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 13844/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The public procurement for this type of medicine is carried out once a year in continuity. The amount of drugs that will be purchased in this procedure treats patients with chronic disease - multiple sclerosis. The quantity requested is for annual treatment of patients who receive the therapy in Continuity without interruption in the long run and a possible interruption of it would mean endangering the health of persons.ocrelizumab-920 mg/23 ml (40 mg/ml), cladribine-10 mg,
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicines-3 - Macedonia Tender
The PHI UNIVERSITY CLINIC OF NEUROLOGY, a Government sector organization in Macedonia, has announced a new tender for Medicines-3. This tender is published on MacedoniaTenders under MKT Ref No: 123584301 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-01.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
